Moleculin Biotech

MBRX

Börsenwert 8,02 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Citigroup New York	25.747 $	+67.654 $	+165	+2.750 %
2	2 XTX Topco George Town, Cayman Islands	22.406 $	+51.253 $	+125	+543 %
3	3 Virtu Financial New York	18.000 $	+48.793 $	+119	Neu
4	4 LPL Financial San Diego, California	16.931 $	+8.200 $	+20	+22 %
5	5 Vanguard Group Malvern, Pennsylvania	9.343 $	–	–	–
6	6 Geode Capital Management Boston, Massachusetts	8.312 $	+1.230 $	+3	+6 %
7	7 Cambridge Investment Research Advisors Fairfield, Iowa	4.000 $	–	–	–
8	8 BlackRock New York	3.738 $	–	–	–
9	9 Truist Financial Charlotte, North Carolina	3.171 $	–	–	–
10	10 UBS Group Zurich, Switzerland	2.413 $	+6.560 $	+16	Neu
11	11 Tower Research Capital (TRC) New York	1.184 $	+2.050 $	+5	+167 %
12	12 Stone House Investment Management Tunkhannock, Pennsylvania	996 $	+2.870 $	+7	Neu
13	13 Newbridge Financial Services Group Boca Raton, Florida	866 $	+1.230 $	+3	+100 %
14	14 Morgan Stanley New York	280 $	–	–	–
15	15 SBI Securities Tokyo, Japan	225 $	–	–	–
16	16 Atlantic Union Bankshares Glen Allen, Virginia	115 $	+410 $	+1	Neu
17	17 Bogart Wealth LLC Mclean, Virginia	91 $	–	–	–
18	18 Bank of America Charlotte, North Carolina	44 $	–	–	–
19	19 Osaic Holdings Scottsdale, Arizona	12 $	–	–	–
20	20 CVA Family Office Denver, Colorado	10 $	–	–	–
21	21 North Star Investment Management Chicago, Illinois	5 $	–	–	–
22	22 Armistice Capital New York	–	-1,22 Mio. $	-2.500	Geschlossen
23	23 Cetera Investment Advisers Schaumburg, Illinois	–	-68.152 $	-140	Geschlossen
24	24 Barclays London, United Kingdom	–	-335 $	-1	Geschlossen
25	25 Fidelity Investments Boston, Massachusetts	–	-33 $	–	–

Moleculin Biotech MBRX Börsenwert 8,02 Mio. $

Moleculin Biotech

MBRX

Börsenwert 8,02 Mio. $